M&A Deal Summary

Viropro Acquires Alpha Biologics Sdn Bhd.

On February 22, 2011, Viropro acquired life science company Alpha Biologics Sdn Bhd.

Acquisition Highlights
  • This is Viropro’s 1st transaction in the Life Science sector.
  • This is Viropro’s 1st transaction in Canada.
  • This is Viropro’s 1st transaction in Quebec.

M&A Deal Summary

Date 2011-02-22
Target Alpha Biologics Sdn Bhd.
Sector Life Science
Buyer(s) Viropro
Deal Type Add-on Acquisition

Target

Alpha Biologics Sdn Bhd.

Montreal, Quebec, Canada
Alpha Biologics Sdn Bhd. is a contract process development and GMP biomanufacturing company, with process development laboratories.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Viropro

San Jose, California, United States

Category Company
Sector Life Science
DESCRIPTION

Viropro is a developer and manufacturer of biopharmaceutical products with a state-of-the-art production. Viropro is based in San Jose, California.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2011 M&A 1 of 1